Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
Clinical trial NCT00299702 · COMPLETED
Trial details
- NCT number
- NCT00299702
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-01-01
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.